These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19735654)

  • 21. Does GDNF exert its neuroprotective effects on photoreceptors in the rd1 retina through the glial glutamate transporter GLAST?
    Delyfer MN; Simonutti M; Neveux N; Léveillard T; Sahel JA
    Mol Vis; 2005 Sep; 11():677-87. PubMed ID: 16163265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation.
    Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-Martínez IT; Young MJ; Herrero-Vanrell R
    Int J Pharm; 2012 Oct; 436(1-2):545-54. PubMed ID: 22828071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BDNF diminishes caspase-2 but not c-Jun immunoreactivity of neurons in retinal ganglion cell layer after transient ischemia.
    Kurokawa T; Katai N; Shibuki H; Kuroiwa S; Kurimoto Y; Nakayama C; Yoshimura N
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3006-11. PubMed ID: 10549664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia.
    Lagrèze WA; Knörle R; Bach M; Feuerstein TJ
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1063-6. PubMed ID: 9579489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.
    Garbayo E; Montero-Menei CN; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
    J Control Release; 2009 Apr; 135(2):119-26. PubMed ID: 19154763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres.
    Ward MS; Khoobehi A; Lavik EB; Langer R; Young MJ
    J Pharm Sci; 2007 Mar; 96(3):558-68. PubMed ID: 17177208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantation of encapsulated glial cell line-derived neurotrophic factor-secreting cells prevents long-lasting learning impairment following neonatal hypoxic-ischemic brain insult in rats.
    Katsuragi S; Ikeda T; Date I; Shingo T; Yasuhara T; Mishima K; Aoo N; Harada K; Egashira N; Iwasaki K; Fujiwara M; Ikenoue T
    Am J Obstet Gynecol; 2005 Apr; 192(4):1028-37. PubMed ID: 15846176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma.
    Ko ML; Hu DN; Ritch R; Sharma SC
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2967-71. PubMed ID: 10967052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pattern electroretinography in a rat model of ocular hypertension: functional evidence for early detection of inner retinal damage.
    Ben-Shlomo G; Bakalash S; Lambrou GN; Latour E; Dawson WW; Schwartz M; Ofri R
    Exp Eye Res; 2005 Sep; 81(3):340-9. PubMed ID: 16129101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuroprotective effect of glial cell line-derived neurotrophic factor in fibrin glue against chronic focal cerebral ischemia in conscious rats.
    Cheng H; Huang SS; Lin SM; Lin MJ; Chu YC; Chih CL; Tsai MJ; Lin HC; Huang WC; Tsai SK
    Brain Res; 2005 Feb; 1033(1):28-33. PubMed ID: 15680336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
    Mittag TW; Danias J; Pohorenec G; Yuan HM; Burakgazi E; Chalmers-Redman R; Podos SM; Tatton WG
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3451-9. PubMed ID: 11006238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of D-allose against retinal ischemia-reperfusion injury.
    Hirooka K; Miyamoto O; Jinming P; Du Y; Itano T; Baba T; Tokuda M; Shiraga F
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1653-7. PubMed ID: 16565406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rabbit retinal neovascularization induced by latex angiogenic-derived fraction: an experimental model.
    Sampaio RB; Mendonca RJ; Simioni AR; Costa RA; Siqueira RC; Correa VM; Tedesco AC; Haddad A; Coutinho Netto J; Jorge R
    Curr Eye Res; 2010 Jan; 35(1):56-62. PubMed ID: 20021255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
    Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
    Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury.
    Shi H; Patschan D; Dietz GP; Bähr M; Plotkin M; Goligorsky MS
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F229-35. PubMed ID: 18003856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection.
    Kilic U; Kilic E; Dietz GP; Bähr M
    Neurodegener Dis; 2004; 1(1):44-9. PubMed ID: 16908973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia.
    Chou AK; Yang LC; Wu PC; Wong WT; Liu GS; Chen JT; Howng SL; Tai MH
    Brain Res Mol Brain Res; 2005 Feb; 133(2):198-207. PubMed ID: 15710236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine.
    Mayor-Torroglosa S; De la Villa P; Rodríguez ME; López-Herrera MP; Avilés-Trigueros M; García-Avilés A; de Imperial JM; Villegas-Pérez MP; Vidal-Sanz M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3825-35. PubMed ID: 16186370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury.
    Shibuki H; Katai N; Kuroiwa S; Kurokawa T; Arai J; Matsumoto K; Nakamura T; Yoshimura N
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):528-36. PubMed ID: 11818401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.